Company Data

Emmaus Life Sciences Incorporation

Ticker
EMMA
Current Price
$0.04 21.21%
Market Cap
$2.6M
Price Target
Refer to Report
Volume
169.8K
52wk Range
$0.0001 - $0.13215
Advanced Market Data

Overview

Emmaus Life Sciences Inc is a biopharmaceutical company engaged in the discovery, development, and commercialization of new treatments and therapies primarily for rare and orphan diseases. The company’s commercial product is Endari, an oral pharmaceutical grade L-glutamine treatment indicated to reduce acute complications of sickle cell disease in adult and pediatric patients five years of age and older. Its products in the pipeline include Diverticulosis and Cell Sheet Engineering.

Inbox Intel from Channelchek.

Informed investors make more money. And itā€™s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy